Tigecycline (Fresenius Kabi USA, LLC)


Welcome to the PulseAid listing for the Tigecycline drug offered from Fresenius Kabi USA, LLC. This Tetracycline-class Antibacterial [EPC],Tetracyclines [Chemical/Ingredient] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Fresenius Kabi USA, LLC
NON-PROPRIETARY NAME: Tigecycline
SUBSTANCE NAME: TIGECYCLINE
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Tetracycline-class Antibacterial [EPC],Tetracyclines [Chemical/Ingredient]
ROUTE: INTRAVENOUS
DOSAGE FORM: INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2016-10-05
END MARKETING DATE: 0000-00-00


Tigecycline HUMAN PRESCRIPTION DRUG Details:

Item DescriptionTigecycline from Fresenius Kabi USA, LLC
LABELER NAME: Fresenius Kabi USA, LLC
DEA SCHEDULE:
ACTIVE STRENGTH: 50(mg/5mL)
START MARKETING DATE: 2016-10-05
END MARKETING DATE: 0000-00-00
PRODUCT ID: 63323-960_078132f8-6dd7-4c8d-bd65-8d44bafe6778
PRODUCT NDC: 63323-960
APPLICATION NUMBER: NDA205645

Other TIGECYCLINE Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Fresenius Kabi USA, LLCTigecycline
Wyeth Pharmaceuticals Inc., a subsidiary of Pfizer Inc.Tygacil